ABSTRACT: The natural polyphenol resveratrol stimulates sirtuins and extends lifespan. Here resveratrol inhibited expression of replicative senescence marker INK4a in human dermal fibroblasts, and 47 of 19,000 genes from microarray experiments were differentially expressed. These included genes for growth, cell division, cell signaling, apoptosis, and transcription. Genes involved in Ras and ubiquitin pathways, Ras-GRF1, RAC3, and UBE2D3, were downregulated. The changes suggest resveratrol might alter sirtuin-regulated downstream pathways, rather than sirtuin activity. Serum deprivation and high confluency caused nuclear translocation of the SIRT1-regulated transcription factor FOXO3a. Our data indicate resveratrol's actions might cause FOXO recruitment to the nucleus.
INTRODUCTION
Calorie restriction (CR) increases the mean and maximum lifespan of all species tested. 1 This involves an increase in the activity and/or abundance of sirtuins, a conserved family of NAD + -dependent deacetylases. 1 Resveratrol (trans-3,5,4 -trihydroxystilbene), a polyphenol found in grape skins and red wine, has also been shown to increase the median and maximum lifespan of a variety of organisms, 2, 3 and may do so by activation of sirtuin-mediated deacetylation. 2 This mechanism, has, however, been disputed. 4, 5 Resveratrol affects other pathways, including those involving activation of phosphatidylinositol 3-kinase (PI3K), 6 inhibition of protein kinase B, 7 and inhibition of the effects on transcription of AP-1 and NF-B. 8 Importantly, studies of the effect of resveratrol in human models of aging are lacking.
The aim of the present study was first to test the effect of resveratrol on the number of cumulative population doublings (CPDs) required to reach replicative senescence in mortal human foreskin fibroblasts, and then to similarly test nicotinamide, an inhibitor of the human sirtuin homolog SIRT1, 9 to see whether SIRT1 inhibition might have an effect on senescence opposite to that of resveratrol. The expression of INK4a has been shown to increase in many organs in aging mice, and this increase is attenuated by CR. 10 In addition, INK4a deficiency prevents an aging-related phenotype in mouse hematopoietic stem cells 11 and other cells, pointing to its involvement in the aging process. We therefore measured INK4a mRNA in order to monitor the effects of resveratrol and nicotinamide on replicative senescence of these cells. To gain a clearer picture of the mechanism of resveratrol's action on mortal human fibroblasts, we used oligonucleotide microarrays to determine global gene expression changes induced by acute treatment with this natural polyphenol. We also determined the localization of the mammalian forkhead box O transcription factor homolog, FOXO3a, in our cell culture model. Overexpression or increased transcriptional activity of FOXO homologs increases lifespan of Drosophila 12 and IGF-KO mice. 13 In nematodes, at least, increased lifespan conferred by Sir-2.1 overexpression is dependent on the presence of functional Daf-16 (a nematode FOXO homolog).
14 In mammalian cells, deacetylation of FOXO proteins by SIRT1 stimulates transcription of genes involved in resistance to cellular stress and cell survival. [15] [16] [17] Thus, by mapping FOXO3a localization, we hoped to gain further insight into the interaction between resveratrol, SIRT1, and FOXO transcription factors in our cell model.
MATERIALS AND METHODS

Cell Culture
Mortal human diploid foreskin fibroblasts (FB0603 cells) at passage 1 were cultured at 37
• C under 5% CO 2 in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA) containing 5% fetal bovine serum (FBS), 80 units/mL penicillin, and 80 g/mL streptomycin (Sigma, St. Louis, MO).
Real-Time RT-PCR
RNA used for real-time quantitative (q) reverse transcription (RT)-PCR analysis as well as for the microarray analysis were extracted using the SV Total RNA Isolation System (Promega, Madison, WI). An SYBR green-based qRT-PCR kit (Qiagen, Hilden, Germany) was used according to the manufacturer's instructions, except for minor changes in the 25-L final volume, with 2.5 L of gene-specific forward primer (0.5 M) (TABLE 1) being added after completion of the RT step. qRT-PCR was performed using a RotorGene 3000 (Corbett Research, Sydney, Australia) instrument. Bestkeeper 18 and REST 19 freeware were used to calculate amplification efficiency. A P < 0.05 was accepted as statistically significant. Results for nicotinamide treatment were normalized to values for mRNA encoding ␤-actin and GAPDH. Interestingly, we found that ␤-actin and GAPDH expression were regulated by resveratrol (data not shown). Thus the qRT-PCR results for resveratrol treatment were normalized to total RNA input.
Intracellular Localization Studies
FB0603 cells were seeded onto 8-well Labtek Permanox chamber slides (Nunc, Rochester, NY) and allowed to grow to various levels of confluency. The cells were incubated with medium containing different concentrations of FBS (1-5%). After 4-h incubation, the cells were fixed with ice-cold absolute methanol for 2 min and blocked with 10% (w/v) BSA for 1 h. Cells were then incubated with goat polyclonal anti-FOXO3a antibody (1:500 in PBS) (Abcam, Cambridge, UK) for 1 h, followed by incubation with secondary donkey antigoat IgG, Alexa 495-conjugated antibody (1:500 in PBS) (Invitrogen) for 1 h. Nuclei were stained by incubating cells with 4 -6-diamidino-2-phenylindole (DAPI) (0.1 g/mL in PBS) for 1 min. Cells were visualized with an Axioplan microscope and photographed with an AxioCam camera (both Zeiss, Oberkochen, Germany).
Microarray Analysis
Normal postmitotic, quiescent foreskin fibroblasts of low (<8) passage were treated with 1 M resveratrol in 0.01% dimethylsulfoxide (DMSO; Sigma) or 0.01% DMSO control for 24 h and then harvested for RNA extraction. RNA integrity was analyzed using an RNA 6000 LabChip on a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Dye assignments were swapped for each biological replicate to eliminate gene-specific dye bias (n = 2). Compugen 19K human oligonucleotide arrays from the Adelaide Microarray Facility (University of Adelaide, Adelaide, South Australia) were used. Each slide consists of 20,000 spots (18,889 oligonucleotides and 1111 control spots), with no duplicate oligonucleotide spots except for GAPDH. RNA (20 g) was reversetranscribed to cDNA according to the manufacturer's instructions (Invitrogen) with minor amendments of addition of 1.35 L of 10 mM amino allyl-dUTP (Sigma) for subsequent dye incorporation. The protocol involved incubation at 42
• C for 2.5 h after 2 L of Superscript III (Invitrogen) was added. The reaction was inactivated by addition of 5 L of 0.5 M EDTA. RNA-DNA heteroduplexes were hydrolyzed at 65
• C with 10 L of 0.25 M NaOH, and then neutralized with 15 L of 0.2 M acetic acid. This was then purified using a column-based PCR clean-up kit (Qiagen), except that nuclease-free water was used instead of elution buffer. The eluents were then dried in a Speed-Vac (Savant, Waltham, MA) set at 45
• C for approximately 20 min or until they
TM or 2 L Cy5 TM dyes (GE Healthcare Life Sciences, Chalfont St. Giles, Bucks, UK) was assigned to respective eluents with 9 L of 0.1 M NaHCO 3 added, and then incubated at room temperature in the dark for 1 h. The dyes were resuspended in 20 L of DMSO. Cy-dye-labeled cDNAs were purified to remove unincorporated dye (Qiagen), and then concentrated again to 1-2 L using a Speed-Vac at 45
• C. Prior to this, the slides were treated as follows: post-printing treatment of the Compugen 19K arrays was performed by baking at 80
• C for 80 min. The prehybridization treatment included 0.1% sodium dodecyl sulfate (SDS) at 95
• C for 1 min, 5% ethanol for 1 min at room temperature, double-distilled water for 1 min, and drying by centrifugation at 100g. The blocking step was performed immediately before hybridization. The purified Cy-dye-labeled cDNAs were then added to 50 L DIG Easy Hyb buffer (Roche, Basel, Switzerland). In addition, 4 L yeast tRNA (25 mg/mL) and 10 L herring sperm DNA (10 mg/mL) were added to reduce nonspecific hybridization. For each biological replicate, DMSO vehicle and resveratrol-treated labeled cDNA solutions were added accordingly. This cocktail was then incubated at 65
• C for 5 min and centrifuged at 13,000g for 5 min. The solution was then applied to a microarray slide covered with a 25 mm × 60 mm Lifterslip (Erie Scientific, Portsmouth, NH). Bubbles were reduced by applying this from the top right corner by capillary action. Then the slides were sealed in a humidified chamber and incubated in a 37
• C oven overnight (13-18 h). Post-hybridization wash was done 3 times in 1× standard saline citrate (SSC), 0.1% SDS for 15 min at 50
• C, 3 times in 1× SSC for 1 min at 50
• C, and once in 0.2× SSC at 50
• C for 1 min, all with continuous agitation. After drying by centrifugation at 800g at room temperature, the slides were scanned using a GenePix 4000B Microarray Scanner (Axon Instruments, Sunnyvale, CA). Manual flagging was used to eliminate misprinted spots from subsequent analysis. Intensities were calculated from the red and green channels and background was corrected using the median measure of pixel intensities. Ratios of corrected intensities for each gene were calculated and the output was saved in a tab-delimited file. The ratio data were analyzed using the LIMMA package in "R". 20 The LIMMA GUI interface was used to interact with the LIMMA package. Print-tip LOESS normalization was used for within-array normalization, and scale-type normalization was used for between-array normalization. A criterion of twofold or greater change in expression was applied to identify differentially expressed genes. These were annotated with the web-based software tool Database for Annotation, Visualization, and Integrated Discovery (DAVID).
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RESULTS
Effect of Long-Term Treatment of Cells with Resveratrol and Nicotinamide
In vehicle (DSMO)-treated cells, INK4a mRNA changed little after 10 CPDs (46 days) (FIG. 1A) . In contrast, the low dose of resveratrol caused a significant (P < 0.001) decrease in INK4a mRNA by 24 h, and this level was maintained through to 10 CPDs. The higher dose of resveratrol also decreased INK4a mRNA. At 10 CPDs another marker of replicative senescence, ␣ 2 -macroglobulin mRNA, was reduced by 0.2 M and 1 M resveratrol to 44% and 46%, respectively.
In contrast, with nicotinamide treatment, a significant (P < 0.001) dosedependent increase in INK4a mRNA by 10 CPD (57 days) was observed (FIG. 1B) .
Effect of Nicotinamide and Resveratrol on Cell Division and Replicative Senescence
Cells were passaged at a 1:4 ratio, so it was assumed that for each passage the cells had undergone 2 CPDs. The cells were considered replicatively senescent when they had not divided after 4 weeks. Resveratrol treatment did not alter the rate of cell division compared to vehicle-treated controls, and both groups reached replicative senescence after 23 CPDs (FIG. 2A) . Cells treated with 0.5 and 5 mM nicotinamide, however, reached replicative senescence after 25 CPDs (FIG. 2B) .
Global Gene Expression Changes by Acute Resveratrol Treatment
The expression of 47 genes (21 with known function) changed by ≥ twofold in response to 24-h resveratrol. Those genes whose function is known are listed in TABLE 2. They included genes involved in the Ras pathway, apoptosis, cell growth and division, G-protein signaling, cell-cell adhesion, immune system regulation, neuroendocrine signaling, muscle development, transcription, and proteolysis.
Validation of Microarray Results by qRT-PCR
One gene (UBE2D3) was selected for RT-PCR to confirm array reliability. Its expression was normalized to a reference gene for cyclophilin D. Consistent with the microarray result in TABLE 2, qRT-PCR, performed in triplicate, showed that UBE2D3 was significantly downregulated (P < 0.001). This provides preliminary support for the veracity of the data in TABLE 2. Confirmation of each gene change by mRNA quantification will require considerable further work. 
FOXO3a Localization
With 5% serum in the culture medium FOXO3a was entirely cytoplasmic, whereas with 1% serum its localization was nuclear (FIG. 3) . Similarly, FOXO3a was predominantly localized in the cytoplasm at low confluency, whereas at high confluency FOXO3a was nuclear. There was, moreover, an additive effect of confluency and serum concentration on FOXO3a localization.
DISCUSSION
We found that resveratrol downregulates expression of Ras-GRF1, which encodes an AP-1-inducible Ras guanine nucleotide exchange factor that upregulates Ras activity. 22 This adds to resveratrol's known ability to reduce AP-1 transcriptional activity. 8 We also found that RAC3 mRNA was similarly downregulated twofold. RAC3 stimulates c-Jun to activate AP-1. 23 Therefore, the reduction in Ras-GRF1 expression may be secondary to the downregulation by resveratrol of RAC3 expression. Thus we find resveratrol likely downregulates the Ras pathway. Active Ras binds to and activates PI3K, a downstream effector of the insulin/IGF-1 growth factor pathway. 24 PI3K then activates protein kinase B, which phosphorylates FOXO3a and causes it to translocate to the cytoplasm. 24 Inhibition of Ras signaling by resveratrol would counter FOXO3a phosphorylation, so increasing its activity.
Like others 25 we found that FOXO3a localization was affected by serum concentration. Serum activates the insulin/IGF-1 growth factor pathway, leading to phosphorylation of FOXO3a and its sequestering in the cytoplasm, thus terminating its transcriptional influence. We now demonstrate that confluency also affected FOXO3a localization. At higher confluencies, fibroblasts undergo density-dependent reversible G1 cell cycle arrest, 26 and changes in FOXO3a localization could contribute to this. Indeed, FOXO3a can induce G1 cell cycle arrest. 15 Of interest, p27 kip1 and GADD45 have been implicated in densitydependent cell cycle arrest 27 and FOXO3a upregulates p27 kip1 expression, 15 leading to increased GADD45. 27 Therefore FOXO3a could directly contribute to density-dependent cell cycle arrest.
Resveratrol also downregulated UBE2DE3, an E2 enzyme involved in protein ubiquitination. E2 enzyme activity is reduced in the liver of CR mice, possibly because of reduction in oxidative stress in CR animals. 28 This might involve a reduction in oxidative damage to proteins, thereby reducing the rate of protein turnover, indicated by reduced E2 activity. E2 activity increases, moreover, with age in mouse liver, and this increase is prevented by CR. 28 The reduction in UBE2DE3 seen may indicate that resveratrol is mimicking CR by the reduction of cellular stress. This could be mediated by increased FOXO3a transcriptional activity. IB␣ is part of a three-protein complex that is bound to NF-B and that blocks its nuclear import and subsequent transcriptional activity.
29 UBE2D3 mediates conjugation of ubiquitin to IB␣, and the degradation of IB␣ allows NF-B to enter the nucleus and activate transcription of target genes. 29 Thus reduced UB2D3 after acute resveratrol would decrease NF-B activity. Resveratrol can decrease NF-B activity, 8 and this then leads to an increase 30 or decrease 31 in stress-induced apoptosis, depending on cell type. The reduction of ubiquitin conjugation by resveratrol as a result of its reduction of UBE2D3 may be the mechanism behind reduced NF-B signaling. NF-B activation, along with stress-induced apoptosis, is increased by oxidative stress. 31 It is thus possible that resveratrol decreases oxidative stress, and that this manifests itself as a decrease in UBE2D3, which would lead to a reduction in NF-B activation, and consequently, a reduction in stress-induced apoptosis. Last, SIRT1 has been shown to inhibit NF-B by a separate mechanism. 30 Thus the effects of SIRT1 and resveratrol overlap, and may help reconcile the confusion in the literature regarding the relationship of resveratrol with SIRT1 signaling.
Our study has also shown that chronic, but not acute, nicotinamide treatment increased INK4a expression. In contrast, acute low-dose resveratrol treatment decreased INK4a expression, and it is probable that chronic low-dose resveratrol has a similar effect. Nicotinamide inhibits SIRT1 activity with an IC 50 < 50 M.
9 Therefore, assuming adequate uptake of nicotinamide, SIRT1 should have been completely inhibited in our study. SIRT1 increases stress resistance and repair in a variety of cell types via modulation of FOXO activity and effects on other pathways.
1 Thus, SIRT1 inhibition should increase susceptibility to damage, and thus increase INK4a expression. Resveratrol, on the other hand, decreased INK4a acutely, perhaps indicating a decrease in cellular damage, and this occurred on a much shorter timescale than that seen for the effect of nicotinamide. FOXO3a was predominantly cytoplasmic in the presence of growth factors. Thus in the control cells, FOXO3a would be unable to activate target genes. SIRT1 is a nuclear protein, and FOXO3a must enter the nucleus in order to interact with SIRT1 and induce stress resistance and repair genes. 15 We propose that inhibition of SIRT1 by nicotinamide has only a minor effect on repair and stress resistance, since only a small fraction of the total cellular FOXO3a pool was in the nucleus under the cell culture conditions used. Thus, it would take a long time for damage to accumulate to a significantly greater amount in the nicotinamide-treated than in the control cells. Resveratrol downregulates the Ras pathway. We therefore propose that resveratrol does not allosterically activate SIRT1, but rather stimulates interaction of SIRT1 with FOXO3a by inducing FOXO3a nuclear localization through the downregulation of Ras activity. Therefore, an increase in FOXO3a transcriptional activity by resveratrol might quickly decrease cellular damage, thereby leading to a decrease in INK4a expression, and consequently attenuate replicative senescence. Given that INK4a is induced by Ras overexpression as a tumor-suppressor mechanism, 32 the decrease in INK4a expression would be due directly to a reduction in Ras pathway activity.
Chronic resveratrol treatment did not increase the time required to reach replicative senescence, despite likely beneficial effects of resveratrol in reducing cellular damage, as judged by the reduction in INK4a it induced. On the other hand, reduced cellular p16 ink4a should have a favorable effect on physiological function at the organismal level, unrelated to its effect on lifespan of fibroblasts. Effects on other cell types could, moreover, be quite different.
Chronic nicotinamide increased the time our fibroblasts required to reach replicative senescence. Although nicotinamide inhibits sirtuin activity, it also influences mitochondrial function. 33 Complex I of the respiratory chain is a key site of ROS generation during oxidative phosphorylation. Curiously, mitochondria that perform their major physiological function of ATP synthesis impose less oxidative danger to cells than do resting mitochondria, despite the multiple sites in mitochondria with the capacity to generate ROS. 33 Despite nicotinamide being the precursor of NADH, and ROS formation being increased by elevation in NADH:NAD + ratio, nicotinamide has been reported to protect against mitochondial damage and oxidative stress, as least in neuronal cells. 33 Further work is, however, required to explain the effect we observed of nicotinamide on time to replicative senescence.
In conclusion, resveratrol may decrease replicative senescence marker expression by inducing the localization of FOXO3a (and possibly other FOXO proteins) to the nucleus, thus promoting FOXO-dependent gene expression. Consequently, by regulating the subcellular localization of FOXO transcription factors, possibly through Ras pathway modulation, resveratrol can mimic the effects of CR.
